Volastra

New York, US · 4 known investors

Volastra is a clinical-stage biotechnology company developing oncology therapeutics that target chromosomal instability in cancer cells. The company uses proprietary technology and screening techniques to identify vulnerabilities in chromosomally unstable cancers and develop treatments through synthetic lethality and immune activation approaches.